How New Immunotherapy is Helping to Treat Melanoma

Translate to Spanish or other 102 languages!

The single-dose immunotherapy is currently approved for those with advanced stage 4 melanoma who have not had success with other treatments. Image for illustration purposes
The single-dose immunotherapy is currently approved for those with advanced stage 4 melanoma who have not had success with other treatments. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – Melanoma is considered the deadliest of all skin cancers.

However, a new FDA approved immunotherapy could help extend lives for some.

“This is the first of its kind personalized immunotherapy for patients with melanoma who’ve progressed on prior therapies,” explained Thach-Giao Truong, MD, oncologist and medical director of the melanoma program at Cleveland Clinic. “It is very unique because it’s a treatment that’s made directly from patients’ own tumors.”

- Advertisement -

The single-dose immunotherapy is currently approved for those with advanced stage 4 melanoma who have not had success with other treatments.

The process works by surgically removing a piece of the patient’s tumor and then identifying specific cancer-fighting immune cells from it.

From there, the cells are multiplied and reinfused through an IV.


By doing this, the patient’s own immune cells can go on to identify and fight the cancer.

- Advertisement -

Dr. Truong said immunotherapy-based treatments are a very effective way to fight melanoma.

In fact, eight-year data from older immune treatment strategies used to date, show 80% of people who respond to initial treatment continue to do well off medication.

“Today, we know that if you get a response on treatment, we’ll see that relatively early in the first few months, that you have a very great chance of being one of those 80% at eight years,” said Dr. Truong. “And in just a short while, the survival from melanoma since the advent of immunotherapy, it’s now at five years, more than half of people remain alive with stage 4 disease.”

Cleveland Clinic is one of 23 facilities across the United States to offer this kind of immunotherapy for advanced stage 4 melanoma.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

New Book Gives Families Language to Discuss Epilepsy

Each November, National Epilepsy Awareness Month invites people to learn how to recognize and respond to a seizure. 

Study Links Higher Vitamin D Levels to Better Sleep

Higher vitamin D levels were associated with longer and less interrupted sleep in middle-aged and older adults, in a study led by researchers at the Johns Hopkins Bloomberg School of Public Health in collaboration with scientists at the National Institute on Aging.

Caring for Others Starts With Caring for Yourself

November is National Family Caregivers Month. Whether you're caring for an aging parent or a loved one with a chronic illness, caregiving can be stressful. It's important to remember taking care of yourself is just as important.

Mayo Clinic Study Sheds New Light on Memory Loss

A new framework, published in Brain, could reshape researchers' understanding of how the brain creates memories and experiences, and how disruptions in this process may indicate Alzheimer’s disease and other forms of dementia.
- Advertisement -